<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00485225</url>
  </required_header>
  <id_info>
    <org_study_id>EN3270-201</org_study_id>
    <nct_id>NCT00485225</nct_id>
  </id_info>
  <brief_title>Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain</brief_title>
  <official_title>An Open-Label, Two-Stage, Phase II Study to Explore the Titration Schedule for Transitioning Opioid-Experienced Patients With Non-Malignant Moderate to Severe Chronic Pain From Current Opioid Therapy to EN3270.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Durect</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Durect</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two stage study looking at different titration schedules in patients with moderate to severe&#xD;
      non-malignant chronic pain. Up to 80 patients at approximately 15 centers in the US to be&#xD;
      enrolled. Study participation is approximately 3 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety and minimum titration period</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">77</enrollment>
  <condition>Chronic, Non Malignant Pain</condition>
  <arm_group>
    <arm_group_label>Transdermal patch (EN3270) - Titration 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Transdermal patch (EN3270) - Titration 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Transdermal patch (EN3270) - Titration 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Transdermal patch (EN3270) - Titration 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EN3270</intervention_name>
    <description>Transdermal Therapeutic System</description>
    <arm_group_label>Transdermal patch (EN3270) - Titration 1</arm_group_label>
    <arm_group_label>Transdermal patch (EN3270) - Titration 2</arm_group_label>
    <arm_group_label>Transdermal patch (EN3270) - Titration 3</arm_group_label>
    <arm_group_label>Transdermal patch (EN3270) - Titration 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Opioid experienced&#xD;
&#xD;
          -  Hx (min 3 months) of moderate to severe pain of non-malignant that is well controlled&#xD;
             with current pain therapy&#xD;
&#xD;
          -  On a stable dose of opioid medication for greater than or equal to 14 days&#xD;
&#xD;
          -  Have an adequate personal support system including a co-habitant&#xD;
&#xD;
          -  Are able and willing to follow verbal and written instructions and provide written&#xD;
             informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Are pregnant or lactating&#xD;
&#xD;
          -  Have pain secondary to a confirmed or suspected neoplasm&#xD;
&#xD;
          -  Have a history or physical examination finding incompatible with safe participation in&#xD;
             the study&#xD;
&#xD;
          -  Have a history of alcohol or drug abuse&#xD;
&#xD;
          -  Have a history or physical examination finding of clinically significant skin&#xD;
             abnormalities that would preclude use of a transdermal patch (e.g., psoriasis)&#xD;
&#xD;
          -  Have a history of or currently manifesting a clinically significant psychiatric&#xD;
             disorder&#xD;
&#xD;
          -  Have a known history of allergy that negatively impacts respiratory function to a&#xD;
             clinically significant level&#xD;
&#xD;
          -  Plan to have an MRI while on the study&#xD;
&#xD;
          -  Have any clinically significant condition that would, in the opinion of the&#xD;
             investigator, preclude safe study participation&#xD;
&#xD;
          -  Are scheduled for surgery requiring general anesthesia within the study period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Comprehensive Clinical Research</name>
      <address>
        <city>Berlin</city>
        <state>New Jersey</state>
        <zip>08009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <study_first_submitted>June 8, 2007</study_first_submitted>
  <study_first_submitted_qc>June 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2007</study_first_posted>
  <disposition_first_submitted>February 21, 2012</disposition_first_submitted>
  <disposition_first_submitted_qc>February 21, 2012</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">February 23, 2012</disposition_first_posted>
  <last_update_submitted>February 21, 2012</last_update_submitted>
  <last_update_submitted_qc>February 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

